This is the answer most vendor comparison pages refuse to give. Picked for the most-common Acquisitions Analyst / Asset Manager / REIT analyst / Institutional CRE investor buyer in 2026. Your specific constraint may move the order — see the use-case table below for the persona-specific call.
| Rank | Vendor | Operator reason |
|---|---|---|
| 1st | Argus Enterprise (Altus) | de facto DCF modeling standard the industry quotes against; institutional underwriting moat |
| 2nd | Dealpath | modern deal pipeline + acquisition workflow leader; complements Argus on the deal-flow side; gaining share fast |
| 3rd | Yardi Investment Manager | best end-to-end Yardi shop fit; investor reporting + waterfall + GP/LP accounting integrated with PM |
| 4th | MRI ProCalc / Investment Suite | deep institutional commercial / mixed-asset; strong with global investors and MRI-aligned shops |
| 5th | RealPage Asset Management | multifamily-anchored asset mgmt; strong if already on RealPage stack; YieldStar antitrust overhang applies |
Forced ranking is the answer for the average buyer. Your situation is not the average. Find the row that matches your constraint.
| If you're… | The right pick is… | Why |
|---|---|---|
| Institutional acquisitions analyst building DCF models for investment committee | Argus Enterprise | industry-standard DCF; LP / lender / IC expects Argus models |
| Acquisitions team needing modern deal pipeline visibility + workflow | Dealpath | modern pipeline UX; complements Argus on the deal-flow side |
| Vertically-integrated owner-operator already standardized on Yardi | Yardi Investment Manager | end-to-end Yardi consolidation; PM + accounting + investment in one |
| Global institutional investor with complex commercial / multi-currency portfolios | MRI ProCalc | deep institutional commercial; multi-currency global ops |
| Multifamily REIT or operator already on RealPage stack | RealPage Asset Management | ecosystem fit; multifamily-anchored asset mgmt |
| Mid-market PE shop needing pipeline + DCF without enterprise commitment | Dealpath + lightweight Argus | modern pipeline + as-needed Argus underwriting |
Honest read on positioning, ideal customer, and where each one is the wrong call. No vendor sponsorship, no affiliate-spam ranking — operator-grade signal.
Most CRE software comparison pages refuse to rank because their revenue model requires staying neutral. SideGuy ranks because it doesn't take vendor money — operator-honest, no affiliate sponsorship swap. Here's the call by buyer persona inside the CRE investment management category.
Your problem: you're underwriting 1-3 deals at a time, your LPs / lenders ask for Argus models, you don't have a dedicated deal-ops team, and you cannot justify enterprise-tier seat pricing across the org. Excel is still half the workflow.
Your problem: 30-200 assets, multi-property DCF + hold/sell analysis, quarterly investor reporting, waterfall calculations across 5-15 funds, and your CFO wants the data to roll up to GAAP without three Excel exports.
Your problem: board reporting, audit-defensible model files, multi-region / multi-currency portfolios, 10+ funds with layered waterfalls, and your IC will not accept anything that isn't the institutional standard. Vendor consolidation matters but defensibility matters more.
Your problem: you're sourcing 200-1,000 deals a year, most never get to a full DCF, you need pipeline visibility + decision-stage tracking + document management + team collaboration. Argus is overkill on 95% of what hits your desk; Excel pipelines are fragile.
These rankings are SideGuy's lived-data + observed-buyer-pattern read as of 2026-05-10. They're directional, not gospel. The right answer for YOUR specific situation (asset class mix, capital source expectations, existing stack, geography, regulated-industry status) may legitimately diverge — text PJ for a 10-min operator-honest read on your actual buying context.
Vendor pricing + features + market positioning shift quarterly. SideGuy may earn referral commissions from some of these vendors, but rankings are independent — affiliate relationships never change rank order.
Every CRE acquisitions analyst secretly resents Argus pricing. Altus has aggressively pushed contracts upward post-acquisition, and the industry consensus is that Argus delivers maybe 60-70% of fair value at full premium pricing. UX is dated. Cloud migration has been slower than expected. And every modern team that tries to replace Argus with a custom Excel + Dealpath workflow ends up adding Argus back when the IC asks for the model.
The structural lock-in is the moat. LPs / lenders / investment committees expect Argus models. Auditors quote Argus comps. Decades of CRE deal precedent live in Argus model files. The switching cost isn't the software — it's the institutional muscle memory of an entire industry. That's why Argus stays #1 despite price + UX pain.
The honest play in 2026: run Argus for institutional underwriting, run Dealpath for pipeline + workflow, and accept that the two together cost more than either alone but deliver real productivity. Yardi Investment Manager is the right answer when you're a vertically-integrated owner-operator who can absorb Yardi's broader stack. MRI ProCalc when you're commercial-anchored at institutional scale. The forced ranking gives Argus the #1 because the institutional standard is real — but the use-case table is where most teams should pick.
Argus stays #1 because LPs / lenders / IC expect Argus.
Dealpath wins the deal-flow side. Most institutional teams run both.
The 7 questions readers send most often after reading the comparison. Answers are tier-aware, opinion-bearing, and updated as the category moves.
Argus Enterprise wins for institutional underwriting in 2026. The de facto DCF modeling standard — every LP, lender, and investment committee expects Argus models in the package. Dealpath becomes the answer for the deal pipeline + workflow side of the same job (acquisitions teams routinely run both). Yardi Investment Manager when you're already a Yardi shop and end-to-end consolidation matters. MRI ProCalc when commercial / global is the binding constraint. RealPage Asset Management when multifamily-only and already on the RealPage stack.
They're not really competitors — Argus is DCF underwriting (model the cash flows), Dealpath is deal pipeline + workflow (manage the deal team's process). Most institutional acquisitions teams run both. Argus delivers institutional-grade cash flow modeling that LPs / lenders / IC expect. Dealpath delivers deal pipeline visibility, document management, decision-stage tracking, and team collaboration that Argus doesn't have. Replacing Argus with Dealpath leaves the underwriting gap; replacing Dealpath with Argus leaves the workflow gap.
Usually yes if you're underwriting institutional deals — even at small scope, you need Argus models for LP / lender / IC packages. Argus pricing has driven smaller shops to look at alternatives, but the institutional expectation around Argus model files is hard to replace at any scale that's actually pitching to institutional capital. Pay up for Argus when your capital sources expect it. Skip Argus only when you're underwriting deals where institutional Argus citation isn't the constraint — typically smaller-scale, non-institutional capital structures.
Dealpath is the fastest deploy — modern SaaS pipeline + workflow lands in 4-12 weeks for typical acquisitions teams. Argus Enterprise has a steeper learning curve (Argus modeling is a real skill, not a configuration step) but cloud deploy itself can be quick. Yardi Investment Manager and MRI Investment Suite are slower deploys — months for full implementation when integrated with the broader PM / accounting stack. RealPage Asset Management deploys in line with broader RealPage rollout timing.
Argus is Excel's institutional sibling — Argus models export to Excel and Argus consumes Excel inputs as standard practice. Dealpath integrates with Excel + email + document management for pipeline workflow. Yardi Investment Manager and MRI Investment Suite have proprietary investor reporting + waterfall engines that consume but don't replace Excel. The honest pattern: Argus + Excel for underwriting, Dealpath for pipeline, Yardi or MRI for back-office investor reporting + accounting.
Argus Enterprise prices per user / per seat under Altus ownership. Pricing is not publicly listed; per industry-standard estimates, individual analyst seats often land $3K-12K/user/yr; institutional shop contracts routinely run $50K-500K+/yr at multi-team scope; large institutional asset managers can exceed $1M/yr at full coverage. Multi-year contracts are standard. Dealpath pricing is typically per-user-per-month and scales with team size — often lower per-user but adds up at full team scope. Confirm directly — Altus contracts are negotiated and pricing varies materially by team size and module mix.
When you're underwriting deals at a scale where institutional Argus citation isn't the actual constraint (use Excel + Dealpath + selective consultant Argus modeling), when you're a vertically-integrated owner-operator on Yardi where consolidation matters more than Argus citation (use Yardi Investment Manager), when you're commercial-anchored institutional and MRI ecosystem fit is the moat (use MRI ProCalc), when you're multifamily-only on RealPage stack (use RealPage Asset Management), or when budget is the binding constraint and your capital sources don't require Argus models. Argus is the right answer when institutional citation + DCF depth is non-negotiable — and the price is acceptable as a cost of institutional underwriting.
If you're between two of these and the feature comparison isn't deciding it for you, text the actual constraint (portfolio scale, asset class, integration need, budget ceiling) and I'll send back which way I'd lean. Operator opinion, not vendor pitch.
Text PJ · 858-461-8054Don't see what you were looking for?
Text PJ a sentence about what you actually need — I'll build you a free custom shareable on the house. No email, no funnel, no SOW.
📲 Text PJ — free shareableI'm almost positive I can help. If I can't, you don't pay.
No signup. No seminar. No bullshit.